Evidence map›Paper›PMID 28832027›Full record

ArticleMucosal immunology2018

Protein kinase C-delta (PKCδ), a marker of inflammation and tuberculosis disease progression in humans, is important for optimal macrophage killing effector functions and survival in mice.

S P Parihar, M Ozturk, M J Marakalala, D T Loots, R Hurdayal, D Beukes Maasdorp, M Van Reenen, D E Zak, F Darboe, A Penn-Nicholson and 5 more

Erratum issuedOpen access · hybridAbstract read
PubMed Publisher
In one paragraph

Article in Mucosal immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 44 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Thrombin-Induced COX-2 Expression and PGEInternational journal of molecular sciences · 2023
    Article
  8. Article
  9. The metabolomics of a protein kinase C delta (PKCδ) knock-out mouse model.Metabolomics : Official journal of the Metabolomic Society · 2022
    Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 2 countries.

S P PariharInstitute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology and South African Medical Research Council (SAMRC) Immunology of Infectious Diseases, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
M OzturkInstitute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology and South African Medical Research Council (SAMRC) Immunology of Infectious Diseases, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
M J MarakalalaInstitute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology and South African Medical Research Council (SAMRC) Immunology of Infectious Diseases, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
D T LootsHuman Metabolomics, North-West University, Potchefstroom, South Africa.
R HurdayalInstitute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology and South African Medical Research Council (SAMRC) Immunology of Infectious Diseases, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
D Beukes MaasdorpHuman Metabolomics, North-West University, Potchefstroom, South Africa.
M Van ReenenHuman Metabolomics, North-West University, Potchefstroom, South Africa.
D E ZakCenter for Infectious Disease Research, Seattle, WA, USA.
F DarboeSouth African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine (IDM) & Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
A Penn-NicholsonSouth African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine (IDM) & Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
W A HanekomSouth African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine (IDM) & Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
M LeitgesPKC Research Consult, Cologne, Germany.
T J ScribaSouth African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine (IDM) & Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
R GulerInstitute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology and South African Medical Research Council (SAMRC) Immunology of Infectious Diseases, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
F BrombacherInstitute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology and South African Medical Research Council (SAMRC) Immunology of Infectious Diseases, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
South African Tuberculosis Vaccine Initiative · ZANorth-West University · ZAUniversity of Cape Town · ZAInternational Centre for Genetic Engineering and Biotechnology · ZACenter for Infectious Disease Research · USSouth African Medical Research Council · ZA

Funding

Technology CoreU19AI106761 · NIAID · SEATTLE BIOMEDICAL RESEARCH INSTITUTE · PI SHERMAN, DAVID R, ZAK, DANIEL E · 2013 to 2017
$18.9M
NIAID NIH HHS U19 AI106761Wellcome Trust 084323
6 · The paper itself

Abstract

We previously demonstrated that protein kinase C-δ (PKCδ) is critical for immunity against Listeria monocytogenes, Leishmania major, and Candida albicans infection in mice. However, the functional relevance of PKCδ during Mycobacterium tuberculosis (Mtb) infection is unknown. PKCδ was significantly upregulated in whole blood of patients with active tuberculosis (TB) disease. Lung proteomics further revealed that PKCδ was highly abundant in the necrotic and cavitory regions of TB granulomas in multidrug-resistant human participants. In murine Mtb infection studies, PKCδ

Indexed as

AdolescentAdultAnimalsBiomarkersCohort StudiesCross-Sectional StudiesCytotoxicity, ImmunologicFemaleGranuloma, Respiratory TractHumansLungMacrophagesMaleMiceMice, Inbred C57BLMice, KnockoutBiomarkersProtein Kinase C-delta

Identifiers

PMID28832027
OpenAlexW2746187103

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.